On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Adipose tissue (AT) general comments
- In vitro methods
- In vivo methods
- AT regulation
- AT components
- Storage mobilization overview
- Lipoprotein lipase (LPL) action
- LPL in various conditions and fat deposits
- Transcapillary flux of fatty acids ( FA)
- Theoretical fate of fatty acids in a cell
- Fat cell fatty acid uptake system
- Fatty acid esterification and TAG synthesis
- Lipid transfer between lipid droplets and the ER
- Regulation of lipolysis and lipid mobilization
- Action of lipases (ATGL, HSL and MGL)
- Hormone sensitive lipase (HSL)
- HSL and ATGL expression
- HSL and ATGL in insulin resistant patients
- HSL and ATGL before/after hypocaloric diet
- Perilipin and ABHB5
- Perilipin, HSL translocation
- Perilipin, ABHD5 interactions
- Epinephrine-induced lipolysis
- Alpha2-adrenergic mediated effect
- Distribution of beta and alpha2-receptors
- Signalling pathways in the control of lipolysis
- Visceral and subcutaneous lipolysis
- Beta-adrenergic receptors polymorphisms
- Natriuretic peptides (ANP, BNP, CNP)
- Physiological role of atrial natriuretic peptides
- Natriuretic peptides and lipolysis
- Type A NP receptors (NPR-A) and ANP signalling
- Signalling pathways: cAMP and cGMP cross-talk
- Other lipolytic/antilipolytic pathways
- Diagram of lipolysis human fat cell - summary
- Sum-up physiological approaches
- Epinephrine response normal /obese
- Systemic NEFA release lean/obese
- Hepatic NEFA delivery
- Effects of intravenous atrial natriuretic peptide
- Diagram of in situ microdialysis
- Isoproterenol and microdialysis of sc AT
- ANP effect on lipolysis and blood flow
- Exercise-induced lipid mobilization
- Lipid mobilization and alpha2-blockade
- Lipid mobilization in trained patients
- Lipid mobilization under beta-blockade
- Role of ANP in lipid mobilization
- Lipolysis perspectives
- TAG perspectives and general conclusions
Topics Covered
- Experimental approaches for study of adipose tissue biology
- Lipoprotein lipase and triacylglycerol hydrolysis
- Fatty acid uptake by fat cells
- Triacylglycerol synthesis
- Lipid droplets
- Adipocyte lipases
- Lipid droplet proteins
- Catecholamine-induced lipolysis
- Catecholamine and insulin signalling pathways
- Natriuretic peptides
- Atrial natriuretic peptide and lipolysis
- Lipid mobilization in lean and obese patients
- In situ microdialysis and lipolysis exploration
- Exercise-induced lipid mobilization in lean and obese
- Role of catecholamines
- Alpha2-adrenergic responsiveness and obesity
- Natriuretic peptides and lipid mobilization
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Lafontan, M. (2009, January 20). Adipose tissue metabolism and obesity [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/OBRE8097.Export Citation (RIS)
Publication History
- Published on January 20, 2009
Financial Disclosures
- Dr. Max Lafontan has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.